Abstract
Telik Inc is developing TLK-286, a modified glutathione analog prodrug, for the potential treatment of cancer.
MeSH terms
-
Animals
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacokinetics
-
Antineoplastic Agents / therapeutic use*
-
Clinical Trials as Topic / trends
-
Drugs, Investigational / chemistry
-
Drugs, Investigational / pharmacokinetics
-
Drugs, Investigational / therapeutic use*
-
Glutathione / analogs & derivatives*
-
Glutathione / chemistry
-
Glutathione / pharmacokinetics
-
Glutathione / therapeutic use*
-
Humans
-
Neoplasms / drug therapy
Substances
-
Antineoplastic Agents
-
Drugs, Investigational
-
TER 286
-
Glutathione